IKNA   $1.71  -1.16% Market Closed

Ikena Oncology Inc
Total Cash 145.42M
totalCashPerShare 3.013
EBITDA -71.34M
Total Debt 9.09M
quickRatio 17.743
currentRatio 18.219
Total Revenue 1.84M
debtToEquity 6.364
Revenue/Share 0.039
ROA -0.27409
ROE -0.44537
grossProfits
freeCashflow -43.63M
operatingCashflow -72.62M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -39.15184
profitMargins 0.0
enterpriseValue -53.32M
forwardPE -1.9770116
floatShares 13.87M
sharesOutstanding 48.26M
sharesShort 147.78K
sharesShortPriorMonth 272.14K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.79%
Short Ratio help_outline 3.87%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 2.96
Price To Book help_outline 0.58
earningsQuarterlyGrowth
netIncomeToCommon -66.71M
trailingEps -1.45%
forwardEps -0.87%
enterpriseToEbitda 0.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.27 3Q 2024
institutionsCount 85
lastUpdated Nov. 7, 2024, 4:59 a.m.